Skip to main content
Top
Published in: Nutrition Journal 1/2011

Open Access 01-12-2011 | Research

Orlistat after initial dietary/behavioural treatment: changes in body weight and dietary maintenance in subjects with sleep related breathing disorders

Authors: Mette Svendsen, Serena Tonstad

Published in: Nutrition Journal | Issue 1/2011

Login to get access

Abstract

Background

Sleep related breathing disorders (SRBD) are associated with increased morbidity and mortality and weight loss is recommended to overweight or obese patients with SRBD. However, maintenance of weight loss is difficult to achieve and strategies for weight loss maintenance is needed. Orlistat is a pharmacological agent that reduces the intestinal absorption of fat and may favour long-term weight maintenance.

Objective

To examine the change in body weight and dietary intake during a 1-year treatment with orlistat after an initial weight loss in obese subjects with SRBD. Furthermore, to explore the dietary determinants of weight maintenance during treatment with orlistat.

Methods

Men and women with SRBD aged 32-62 years (n = 63) participated in a 3-month dietary intervention to increase intake of vegetables and fruit. After an initial weight loss of 3.4 kg they achieved a mean body mass index of 34.3 ± 4.7 kg/m2. Subsequently they were treated with orlistat for 1 year. During this year, dietary and behavioural interventions to attain weight loss were provided in the course of 14 group sessions. Dietary intake, energy density and food choices were assessed with a food frequency questionnaire before and after orlistat treatment.

Results

With orlistat, body weight decreased by a mean of 3.5 kg (95% CI 1.5, 5.5). The dietary E% from saturated fat, intake of fatty dairy products and energy density increased after 1 year while intakes of oils, fish and vegetables decreased (all P < 0.05). After multivariate adjustments, weight loss was associated with E% protein (R2adj = 0.19 [95% CI 0.10, 0.46]), and inversely associated with E% saturated fat (R2adj = 0.20 [95% CI 0.12, 0.47]) and fatty dairy products (R2adj = 0.23 [95% CI 0.12, 0.49]).

Conclusions

Orlistat induced further weight loss, but dietary compliance declined with time. Increasing dietary protein and restricting saturated fat and fatty dairy products may facilitate weight loss with orlistat.
Literature
1.
2.
go back to reference Romero-Corral A, Caples SM, Lopez-Jimenes F, Somers VK: Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest. 2010, 137 (3): 711-719. 10.1378/chest.09-0360.CrossRefPubMedPubMedCentral Romero-Corral A, Caples SM, Lopez-Jimenes F, Somers VK: Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest. 2010, 137 (3): 711-719. 10.1378/chest.09-0360.CrossRefPubMedPubMedCentral
3.
go back to reference Tuomilehto HP, Seppä JM, Partinen MM, Peltonen M, Gylling H, Tuomilehto JO, Vanninen EJ, Kokkarinen J, Sahlman JK, Martikainen T, Soini EJ, Randell J, Tukiainen H, Uusitupa M, Kuopio Sleep Apnea Group: Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea. Am J Respir Crit Care Med. 2009, 179 (4): 320-327. 10.1164/rccm.200805-669OC.CrossRefPubMed Tuomilehto HP, Seppä JM, Partinen MM, Peltonen M, Gylling H, Tuomilehto JO, Vanninen EJ, Kokkarinen J, Sahlman JK, Martikainen T, Soini EJ, Randell J, Tukiainen H, Uusitupa M, Kuopio Sleep Apnea Group: Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea. Am J Respir Crit Care Med. 2009, 179 (4): 320-327. 10.1164/rccm.200805-669OC.CrossRefPubMed
4.
go back to reference Foster GD, Borradaile KE, Sanders MH, Millman R, Zammit G, Newman AB, Wadden TA, Kelley D, Wing RR, Pi-Sunyer FX, Reboussin D, Kuna ST, Sleep AHEAD Research Group of Look AHEAD Research Group: A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. Arch Intern Med. 2009, 169 (17): 1619-1626. 10.1001/archinternmed.2009.266.CrossRefPubMedPubMedCentral Foster GD, Borradaile KE, Sanders MH, Millman R, Zammit G, Newman AB, Wadden TA, Kelley D, Wing RR, Pi-Sunyer FX, Reboussin D, Kuna ST, Sleep AHEAD Research Group of Look AHEAD Research Group: A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. Arch Intern Med. 2009, 169 (17): 1619-1626. 10.1001/archinternmed.2009.266.CrossRefPubMedPubMedCentral
6.
go back to reference Rolls BJ, Drewnowski A, Ledikwe JH: Changing the ED of the diet as a strategy for weight maintenance. J Am Diet Assoc. 2005, 105 (5 Suppl 1): S98-S103. 10.1016/j.jada.2005.02.033.CrossRefPubMed Rolls BJ, Drewnowski A, Ledikwe JH: Changing the ED of the diet as a strategy for weight maintenance. J Am Diet Assoc. 2005, 105 (5 Suppl 1): S98-S103. 10.1016/j.jada.2005.02.033.CrossRefPubMed
7.
go back to reference Rolls BJ, Roe LS, Meengs JS: Portion size can be used strategically to increase vegetable consumption in adults. Am J Clin Nutr. 2010, 91 (4): 913-922. 10.3945/ajcn.2009.28801.CrossRefPubMedPubMedCentral Rolls BJ, Roe LS, Meengs JS: Portion size can be used strategically to increase vegetable consumption in adults. Am J Clin Nutr. 2010, 91 (4): 913-922. 10.3945/ajcn.2009.28801.CrossRefPubMedPubMedCentral
8.
go back to reference Sjöström L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf M, for the European Multicentre Orlistat Study Group: Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet. 1998, 352 (9123): 167-172.CrossRefPubMed Sjöström L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf M, for the European Multicentre Orlistat Study Group: Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet. 1998, 352 (9123): 167-172.CrossRefPubMed
9.
go back to reference Richelsen B, Tonstad S, Rössner S, Toubro S, Niskanen L, Madsbad S, Mustajoki P, Rissanen A: Effect of orlistat on weight regain and on cardiovascular risk factors following a very-low-calorie diet in abdominally obese patients. A three-year-randomised placebo controlled study. Diabetes Care. 2007, 30 (1): 27-32. 10.2337/dc06-0210.CrossRefPubMed Richelsen B, Tonstad S, Rössner S, Toubro S, Niskanen L, Madsbad S, Mustajoki P, Rissanen A: Effect of orlistat on weight regain and on cardiovascular risk factors following a very-low-calorie diet in abdominally obese patients. A three-year-randomised placebo controlled study. Diabetes Care. 2007, 30 (1): 27-32. 10.2337/dc06-0210.CrossRefPubMed
10.
go back to reference Hill JO, Hauptman J, Anderson JW, Fujioka K, O'Neil P, Smith DK, Zavoral JH, Aronne LJ: Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. Am J Clin Nutr. 1999, 69 (6): 1108-1116.PubMed Hill JO, Hauptman J, Anderson JW, Fujioka K, O'Neil P, Smith DK, Zavoral JH, Aronne LJ: Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. Am J Clin Nutr. 1999, 69 (6): 1108-1116.PubMed
11.
go back to reference Franson K, Rössner S: Fat intake and food choices during weight reduction with diet, behaviour modification and a lipase inhibitor. J Intern Med. 2000, 247 (5): 607-614.CrossRefPubMed Franson K, Rössner S: Fat intake and food choices during weight reduction with diet, behaviour modification and a lipase inhibitor. J Intern Med. 2000, 247 (5): 607-614.CrossRefPubMed
12.
go back to reference Svendsen M, Blomhoff R, Holme I, Tonstad S: The effect of an increased intake of vegetables and fruit on weight loss, blood pressure and antioxidant defense in subjects with sleep related breathing disorders. Eur J Clin Nutr. 2007, 61 (11): 1301-1311. 10.1038/sj.ejcn.1602652.CrossRefPubMed Svendsen M, Blomhoff R, Holme I, Tonstad S: The effect of an increased intake of vegetables and fruit on weight loss, blood pressure and antioxidant defense in subjects with sleep related breathing disorders. Eur J Clin Nutr. 2007, 61 (11): 1301-1311. 10.1038/sj.ejcn.1602652.CrossRefPubMed
13.
go back to reference Melin I, Rössner S: Practical clinical behavioral treatment of obesity. Patient Educ Counc. 2003, 49 (1): 75-83. 10.1016/S0738-3991(02)00049-6.CrossRef Melin I, Rössner S: Practical clinical behavioral treatment of obesity. Patient Educ Counc. 2003, 49 (1): 75-83. 10.1016/S0738-3991(02)00049-6.CrossRef
14.
go back to reference Svendsen M, Tonstad S: Accuracy of food intake reporting in obese subjects with metabolic risk factors. Br J Nutr. 2006, 95 (3): 640-649. 10.1079/BJN20051662.CrossRefPubMed Svendsen M, Tonstad S: Accuracy of food intake reporting in obese subjects with metabolic risk factors. Br J Nutr. 2006, 95 (3): 640-649. 10.1079/BJN20051662.CrossRefPubMed
15.
go back to reference Rimestad AH, Blaker B, Færden K, Flåten AM, Lund-Larsen K, Nordbotten K, Trygg K: Den store matvaretabellen (The Norwegian food composition table). 1995, Universitetsforlaget: Oslo Rimestad AH, Blaker B, Færden K, Flåten AM, Lund-Larsen K, Nordbotten K, Trygg K: Den store matvaretabellen (The Norwegian food composition table). 1995, Universitetsforlaget: Oslo
16.
go back to reference Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, McManus K, Champagne CM, Bishop LM, Laranjo N, Leboff MS, Rood JC, de Jonge L, Greenway FL, Loria CM, Obarzanek E, Williamson DA: Comparison of weight loss diets with different compositions of fat, protein and carbohydrates. N Engl J Med. 2009, 360 (9): 859-873. 10.1056/NEJMoa0804748.CrossRefPubMedPubMedCentral Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, McManus K, Champagne CM, Bishop LM, Laranjo N, Leboff MS, Rood JC, de Jonge L, Greenway FL, Loria CM, Obarzanek E, Williamson DA: Comparison of weight loss diets with different compositions of fat, protein and carbohydrates. N Engl J Med. 2009, 360 (9): 859-873. 10.1056/NEJMoa0804748.CrossRefPubMedPubMedCentral
17.
go back to reference Legemiddelverket : Summary of product characteristics (SPC) for Xenical. 2005, Oslo Legemiddelverket : Summary of product characteristics (SPC) for Xenical. 2005, Oslo
18.
go back to reference Ledikwe JH, Rolls BJ, Smickiklas-Wright H, Mitchell DC, Ard JD, Champagne C, Karanja N, Pao-Hwa L, Stevens VJ, Appel LJ: Reduction in dietary ED are associated with weight loss in overweight and obese participants in the PREMIER trial. Am J Clin Nutr. 2007, 85 (5): 1212-1221.PubMed Ledikwe JH, Rolls BJ, Smickiklas-Wright H, Mitchell DC, Ard JD, Champagne C, Karanja N, Pao-Hwa L, Stevens VJ, Appel LJ: Reduction in dietary ED are associated with weight loss in overweight and obese participants in the PREMIER trial. Am J Clin Nutr. 2007, 85 (5): 1212-1221.PubMed
19.
go back to reference Ello-Martin JA, Roe LS, Ledikwe JH, Beach AM, Rolls BJ: Dietary ED in the treatment of obesity: a year-long trial comparing 2 weight-loss diets. Am J Clin Nutr. 2007, 85 (6): 1465-1477.PubMedPubMedCentral Ello-Martin JA, Roe LS, Ledikwe JH, Beach AM, Rolls BJ: Dietary ED in the treatment of obesity: a year-long trial comparing 2 weight-loss diets. Am J Clin Nutr. 2007, 85 (6): 1465-1477.PubMedPubMedCentral
20.
go back to reference Skov AR, Toubro S, Rønn B, Holm L, Astrup A: Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int J Obes Relat Metab Disord. 1999, 23 (5): 528-536. 10.1038/sj.ijo.0800867.CrossRefPubMed Skov AR, Toubro S, Rønn B, Holm L, Astrup A: Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int J Obes Relat Metab Disord. 1999, 23 (5): 528-536. 10.1038/sj.ijo.0800867.CrossRefPubMed
21.
go back to reference Klein S, Sheard NF, Pi-Sunyer X, Daly A, Wylie-Rosett J, Kulkarni K, Clark NG: Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, The North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Am J Clin Nutr. 2004, 80 (2): 257-263.PubMed Klein S, Sheard NF, Pi-Sunyer X, Daly A, Wylie-Rosett J, Kulkarni K, Clark NG: Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, The North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Am J Clin Nutr. 2004, 80 (2): 257-263.PubMed
22.
go back to reference Paddon-Jones D, Westman E, Mattes R, Wolfe RR, Astrup A, Westerterp-Plantenga M: Protein, weight management, and satiety. Am J Clin Nutr. 2008, 87 (5): 1558S-1561S.PubMed Paddon-Jones D, Westman E, Mattes R, Wolfe RR, Astrup A, Westerterp-Plantenga M: Protein, weight management, and satiety. Am J Clin Nutr. 2008, 87 (5): 1558S-1561S.PubMed
23.
go back to reference Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E: Sleep loss: A novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol. 2005, 99 (5): 2008-2019. 10.1152/japplphysiol.00660.2005.CrossRefPubMed Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E: Sleep loss: A novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol. 2005, 99 (5): 2008-2019. 10.1152/japplphysiol.00660.2005.CrossRefPubMed
24.
go back to reference Yee BJ, Phillips CL, Banerjee D, Caterson I, Hedner JA, Grunstein RR: The effect of sibutramine-assisted weight loss in men with obstructive sleep apnea. Int J Obes. 2007, 31 (1): 161-168. 10.1038/sj.ijo.0803363.CrossRef Yee BJ, Phillips CL, Banerjee D, Caterson I, Hedner JA, Grunstein RR: The effect of sibutramine-assisted weight loss in men with obstructive sleep apnea. Int J Obes. 2007, 31 (1): 161-168. 10.1038/sj.ijo.0803363.CrossRef
25.
go back to reference Phillips CL, Yee BJ, Trenell MI, Magnussen JS, Wang D, Banerjee D, Berend N, Grunstein RR: Changes in regional adiposity and cardio-metabolic function following a weight loss program with sibutramine in obese men with obstructive sleep apnea. J Clin Sleep Medicine. 2009, 5 (5): 416-421. Phillips CL, Yee BJ, Trenell MI, Magnussen JS, Wang D, Banerjee D, Berend N, Grunstein RR: Changes in regional adiposity and cardio-metabolic function following a weight loss program with sibutramine in obese men with obstructive sleep apnea. J Clin Sleep Medicine. 2009, 5 (5): 416-421.
Metadata
Title
Orlistat after initial dietary/behavioural treatment: changes in body weight and dietary maintenance in subjects with sleep related breathing disorders
Authors
Mette Svendsen
Serena Tonstad
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Nutrition Journal / Issue 1/2011
Electronic ISSN: 1475-2891
DOI
https://doi.org/10.1186/1475-2891-10-21

Other articles of this Issue 1/2011

Nutrition Journal 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.